Impact of age on the comparison between short-term vs 12-month dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: 2-Year follow-up results of the REDUCE trial

• Main Authors: Kedhi, Elvin, Verdoia, Monica, Suryapranata, Harry, Damen, Sander, Camaro, Cyril, Benit, Edouard, Barbieri, Lucia, Rasoul, Saman, Liew, Houng B., Polad, Jawed, Ahmad, Wan Azman Wan, Zambahari, Robaayah, Lalmand, Jacques, van der Schaaf, Rene J., Koh, Tian H., Timmermans, Philippe, Dilling-Boer, Dagmara, Veenstra, Leo F., van' t Hof, Arnoud W. J., Lee, Stephen W. L., Roolvink, Vincent, Ligtenberg, Erik, Postma, Sonja, Kolkman, Evelien J. J., Brouwer, Marc A., Dudek, Dariusz, De Luca, Giuseppe
• Format: Article
• Published: Elsevier 2021
• Subjects: R Medicine; R Medicine (General)
• Online Access: http://eprints.um.edu.my/34619/

Background and aims: The impact of advanced age on the optimal duration of dual antiplatelet therapy (DAPT) in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary revascularization (PCI) is still greatly debated. Therefore, the aim of the present sub-analysis of the REDUCE t...